CDK9-IN-9 (example 2) is a highly potent and specific CDK9 inhibitor with an IC50 of 1.8 nM. CDK9-IN-9 inhibits CDK2 with an IC50 of 155 nM. CDK9-IN-9 has anti-cancer activity. References: [1]. Ulrich LUCKING, et al. Novel ptefb inhibiting macrocyclic compounds. WO2018177889A1.

纯度：≥98%

CAS：2246956-84-1